361 related articles for article (PubMed ID: 2906344)
1. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
Bonnar J; Daly L; Carroll E
Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344
[TBL] [Abstract][Full Text] [Related]
2. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptives and blood coagulation.
Bonnar J; Sabra AM
J Reprod Med; 1986 Jun; 31(6 Suppl):551-6. PubMed ID: 2941571
[TBL] [Abstract][Full Text] [Related]
4. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
Ferreira AC; Montes MB; Franceschini SA; Toloi MR
Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies of 30 micrograms ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets.
Daly L; Bonnar J
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):430-7. PubMed ID: 2142580
[TBL] [Abstract][Full Text] [Related]
6. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
Lepot MR; Gaspard UJ
Int J Fertil; 1987; 32 Suppl():15-20. PubMed ID: 2906343
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
8. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
Norris LA; Bonnar J
Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
[TBL] [Abstract][Full Text] [Related]
9. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
Petersen KR; Sidelmann J; Skouby SO; Jespersen J
Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
[TBL] [Abstract][Full Text] [Related]
10. [Hemostatic balance during treatment with the newest contraceptives].
Petersen KR; Skouby SO; Sidelmann J; Jespersen J
Ugeskr Laeger; 1994 Jan; 156(2):187-90. PubMed ID: 8296409
[TBL] [Abstract][Full Text] [Related]
11. A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors.
Melis GB; Fruzzetti F; Nicoletti I; Ricci C; Lammers P; Atsma WJ; Fioretti P
Contraception; 1991 Jan; 43(1):23-31. PubMed ID: 1825970
[TBL] [Abstract][Full Text] [Related]
12. Changes in coagulation and fibrinolysis variables during use of two oral contraceptives containing the same dose of ethinyl estradiol and either gestodene or desogestrel.
Gevers Leuven JA; Kluft C; Dersjant-Roorda MC; Harthoorn-Lasthuizen EJ; Peters FP; Bernsen MJ; Helmerhorst FM
Adv Contracept; 1990 Dec; 6 Suppl():69-73. PubMed ID: 2149807
[No Abstract] [Full Text] [Related]
13. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
14. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
[TBL] [Abstract][Full Text] [Related]
15. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
16. Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance.
Rákóczi I; Gerö G; Demeter J; Gáti I
Arzneimittelforschung; 1985; 35(3):630-3. PubMed ID: 3158320
[TBL] [Abstract][Full Text] [Related]
17. Clinical aspects of three new progestogens: desogestrel, gestodene, and norgestimate.
Chez RA
Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1296-300. PubMed ID: 2524163
[TBL] [Abstract][Full Text] [Related]
18. New progestogens in oral contraceptives.
Runnebaum B; Rabe T
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1059-63. PubMed ID: 2960242
[TBL] [Abstract][Full Text] [Related]
19. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
[TBL] [Abstract][Full Text] [Related]
20. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
Sabra A; Bonnar J
J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]